Exact Mass: 321.1953

Exact Mass Matches: 321.1953

Found 68 metabolites which its exact mass value is equals to given mass value 321.1953, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Croomine

Spiro(furan-2(5H),9-(9H)pyrrolo(1,2-a)azepin)-5-one, decahydro-4-methyl-3-(tetrahydro-4-methyl-5-oxo-2-furanyl)-, (3S-(3alpha(2R*,4R*),9alpha(S*),9aalpha))-

C18H27NO4 (321.194)


A natural product found particularly in Stemona tuberosa and Stemona phyllantha.

   

7-Angeloyl-9-(2-methylbutyryl)heliotridine

7-Angeloyl-9-(2-methylbutyryl)heliotridine

C18H27NO4 (321.194)


   

omega-Hydroxycapsaicin

omega-Hydroxycapsaicin

C18H27NO4 (321.194)


   

Lycoposerramine N

Lycoposerramine N

C18H27NO4 (321.194)


   

CFA-L-isoleucine

CFA-L-isoleucine

C18H27NO4 (321.194)


   

(-)3alpha-6beta-ditigloyloxytropane

(-)3alpha-6beta-ditigloyloxytropane

C18H27NO4 (321.194)


   

SCHEMBL4581440

SCHEMBL4581440

C18H27NO4 (321.194)


   

dubiusamine-B

dubiusamine-B

C18H27NO4 (321.194)


   

8beta-acetoxyfawcettimine

8beta-acetoxyfawcettimine

C18H27NO4 (321.194)


   

(5beta,15R)-15-hydroxy-15-methyl-8-oxolycopodan-5-yl acetate|obscurumine G

(5beta,15R)-15-hydroxy-15-methyl-8-oxolycopodan-5-yl acetate|obscurumine G

C18H27NO4 (321.194)


   

8beta-acetoxy-12beta-hydroxylycopodine

8beta-acetoxy-12beta-hydroxylycopodine

C18H27NO4 (321.194)


   

8beta-hydroxy-11alpha-acetoxylycopodine

8beta-hydroxy-11alpha-acetoxylycopodine

C18H27NO4 (321.194)


   
   
   

N-Feruloylspermidine

N-Feruloylspermidine

C17H27N3O3 (321.2052)


   

3-hydroxy-N-(1-hydroxy-4-methylpentan-2-yl)-5-oxo-6-phenylhexanamide

NCGC00347618-02!3-hydroxy-N-(1-hydroxy-4-methylpentan-2-yl)-5-oxo-6-phenylhexanamide

C18H27NO4 (321.194)


   

3-hydroxy-N-(1-hydroxy-4-methylpentan-2-yl)-5-oxo-6-phenylhexanamide [IIN-based on: CCMSLIB00000849085]

NCGC00347618-02!3-hydroxy-N-(1-hydroxy-4-methylpentan-2-yl)-5-oxo-6-phenylhexanamide [IIN-based on: CCMSLIB00000849085]

C18H27NO4 (321.194)


   

3-hydroxy-N-(1-hydroxy-4-methylpentan-2-yl)-5-oxo-6-phenylhexanamide [IIN-based: Match]

NCGC00347618-02!3-hydroxy-N-(1-hydroxy-4-methylpentan-2-yl)-5-oxo-6-phenylhexanamide [IIN-based: Match]

C18H27NO4 (321.194)


   

N-coronafacoyl-L-isoleucine

N-coronafacoyl-L-isoleucine

C18H27NO4 (321.194)


   

3-Hydroxy-N-(1-hydroxy-4-methyl-2-pentanyl)-5-oxo-6-phenylhexanamide

3-Hydroxy-N-(1-hydroxy-4-methyl-2-pentanyl)-5-oxo-6-phenylhexanamide

C18H27NO4 (321.194)


   

N-(3S,4S-methylene-decanoyl) histidine

N-(3S,4S-methylene-decanoyl)-histidine

C17H27N3O3 (321.2052)


   

Tetrabutylammonium bromide

Tetrabutylammonium bromide

C16H36BrN (321.2031)


D013501 - Surface-Active Agents > D003902 - Detergents

   

BOC-L-4-tBu-phe

BOC-L-4-tBu-phe

C18H27NO4 (321.194)


   

azane,1-ethoxybutane,furan-2,5-dione,styrene

azane,1-ethoxybutane,furan-2,5-dione,styrene

C18H27NO4 (321.194)


   

(6-(4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL)-5-METHYLPYRIDIN-3-YL)BORONIC ACID

(6-(4-(TERT-BUTOXYCARBONYL)PIPERAZIN-1-YL)-5-METHYLPYRIDIN-3-YL)BORONIC ACID

C15H24BN3O4 (321.186)


   

4-BROMO-3,5-DIHYDROXYBENZAMIDE

4-BROMO-3,5-DIHYDROXYBENZAMIDE

C14H31NO5Si (321.1971)


   

4-(2-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)morpholine

4-(2-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)morpholine

C17H25BFNO3 (321.1911)


   

2-(tert-Butoxycarbonylamino)pyrimidine-5-boronic acid pinacol ester

2-(tert-Butoxycarbonylamino)pyrimidine-5-boronic acid pinacol ester

C15H24BN3O4 (321.186)


   

2-(9H-CARBAZOLYL)ETHYLBORONIC ACID PINACOL ESTER

2-(9H-CARBAZOLYL)ETHYLBORONIC ACID PINACOL ESTER

C20H24BNO2 (321.19)


   

N-Hexyl-N,N-dimethyl-1-octanaminium bromide

N-Hexyl-N,N-dimethyl-1-octanaminium bromide

C16H36BrN (321.2031)


   

4-Nitrophenyl Laurate

4-Nitrophenyl Laurate

C18H27NO4 (321.194)


   

etoxeridine

etoxeridine

C18H27NO4 (321.194)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent

   

4-(1-Pyrazin-2-yl-ethoxyMethyl)-piperidine-1-carboxylic acid tert-butyl ester

4-(1-Pyrazin-2-yl-ethoxyMethyl)-piperidine-1-carboxylic acid tert-butyl ester

C17H27N3O3 (321.2052)


   

Pentazocine hydrochloride

(+)-PENTAZOCINE MIXED AGONIST/ANTAGON

C19H28ClNO (321.1859)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D009292 - Narcotic Antagonists D002491 - Central Nervous System Agents > D000700 - Analgesics

   

N,N-Diethyl-2-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

N,N-Diethyl-2-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide

C17H25BFNO3 (321.1911)


   

4-(2-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)morpholine

4-(2-Fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)morpholine

C17H25BFNO3 (321.1911)


   

4-(3-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)morpholine

4-(3-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)morpholine

C17H25BFNO3 (321.1911)


   

N-Ethyl-N,N-dimethyl-1-dodecanaminium bromide

N-Ethyl-N,N-dimethyl-1-dodecanaminium bromide

C16H36BrN (321.2031)


   

Boc-D-4-tert-Butylphenylalanine

Boc-D-4-tert-Butylphenylalanine

C18H27NO4 (321.194)


   

Chloroquine dication

Chloroquine dication

C18H28ClN3+2 (321.1972)


   

3-hydroxy-N-(1-hydroxy-4-methylpentan-2-yl)-5-oxo-6-phenylhexanamide

3-hydroxy-N-(1-hydroxy-4-methylpentan-2-yl)-5-oxo-6-phenylhexanamide

C18H27NO4 (321.194)


   

(5S,6R,9R)-14-amino-5-methoxy-3,6,9-trimethyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-2-one

(5S,6R,9R)-14-amino-5-methoxy-3,6,9-trimethyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-2-one

C17H27N3O3 (321.2052)


   

NA-Taurine 13:0

NA-Taurine 13:0

C15H31NO4S (321.1974)


   
   

VU0080241

VU0080241

C19H23N5 (321.1953)


VU0080241 is a positive allosteric modulator (PAM) of the metabotropic glutamate receptor subtype 4 (mGluR4), with an EC50 of 4.6 μM[1].

   

(1s,2s,3s,10s,13s,15r)-2-hydroxy-15-methyl-11-oxo-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-3-yl acetate

(1s,2s,3s,10s,13s,15r)-2-hydroxy-15-methyl-11-oxo-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-3-yl acetate

C18H27NO4 (321.194)


   

(2r,3s,4r,5r)-2-{[(1s,2r,3r,4s,6r)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy}-5-methyl-4-(methylamino)oxane-3,5-diol

(2r,3s,4r,5r)-2-{[(1s,2r,3r,4s,6r)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy}-5-methyl-4-(methylamino)oxane-3,5-diol

C13H27N3O6 (321.19)


   

7-angeloyl-9-(2-methylbutyryl)heliotridine

NA

C18H27NO4 (321.194)


{"Ingredient_id": "HBIN013050","Ingredient_name": "7-angeloyl-9-(2-methylbutyryl)heliotridine","Alias": "NA","Ingredient_formula": "C18H27NO4","Ingredient_Smile": "CCC(C)C(=O)OCC1=CCN2C1C(CC2)OC(=O)C(=CC)C","Ingredient_weight": "321.4 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "37196","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "91748012","DrugBank_id": "NA"}

   

2-hydroxy-15-methyl-11-oxo-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-3-yl acetate

2-hydroxy-15-methyl-11-oxo-6-azatetracyclo[8.6.0.0¹,⁶.0²,¹³]hexadecan-3-yl acetate

C18H27NO4 (321.194)


   

(1s,7ar)-7-({[(2r)-2-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate

(1s,7ar)-7-({[(2r)-2-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate

C18H27NO4 (321.194)


   

8-methyl-3-[(2-methylbut-2-enoyl)oxy]-8-azabicyclo[3.2.1]octan-6-yl 2-methylbut-2-enoate

8-methyl-3-[(2-methylbut-2-enoyl)oxy]-8-azabicyclo[3.2.1]octan-6-yl 2-methylbut-2-enoate

C18H27NO4 (321.194)


   

4-methyl-3'-(4-methyl-5-oxooxolan-2-yl)-octahydrospiro[oxolane-2,9'-pyrrolo[1,2-a]azepin]-5-one

4-methyl-3'-(4-methyl-5-oxooxolan-2-yl)-octahydrospiro[oxolane-2,9'-pyrrolo[1,2-a]azepin]-5-one

C18H27NO4 (321.194)


   

2-[(4,6-diamino-2,3-dihydroxycyclohexyl)oxy]-5-methyl-4-(methylamino)oxane-3,5-diol

2-[(4,6-diamino-2,3-dihydroxycyclohexyl)oxy]-5-methyl-4-(methylamino)oxane-3,5-diol

C13H27N3O6 (321.19)


   

(2r,3s)-2-({[(3as,6r,7as)-6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydroinden-4-yl](hydroxy)methylidene}amino)-3-methylpentanoic acid

(2r,3s)-2-({[(3as,6r,7as)-6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydroinden-4-yl](hydroxy)methylidene}amino)-3-methylpentanoic acid

C18H27NO4 (321.194)


   

(2r,3's,4r,9'ar)-4-methyl-3'-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]-octahydrospiro[oxolane-2,9'-pyrrolo[1,2-a]azepin]-5-one

(2r,3's,4r,9'ar)-4-methyl-3'-[(2s,4s)-4-methyl-5-oxooxolan-2-yl]-octahydrospiro[oxolane-2,9'-pyrrolo[1,2-a]azepin]-5-one

C18H27NO4 (321.194)


   

(1s,2s,4s,5s,6s,9s)-2-hydroxy-4-methyl-8-oxo-13-azatetracyclo[7.7.0.0¹,⁶.0²,¹³]hexadecan-5-yl acetate

(1s,2s,4s,5s,6s,9s)-2-hydroxy-4-methyl-8-oxo-13-azatetracyclo[7.7.0.0¹,⁶.0²,¹³]hexadecan-5-yl acetate

C18H27NO4 (321.194)


   

(1s,2s,4s,5r,6s,9s)-2-hydroxy-4-methyl-8-oxo-13-azatetracyclo[7.7.0.0¹,⁶.0²,¹³]hexadecan-5-yl acetate

(1s,2s,4s,5r,6s,9s)-2-hydroxy-4-methyl-8-oxo-13-azatetracyclo[7.7.0.0¹,⁶.0²,¹³]hexadecan-5-yl acetate

C18H27NO4 (321.194)


   

(1r,3r,5s,6r)-8-methyl-3-{[(2e)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-6-yl (2e)-2-methylbut-2-enoate

(1r,3r,5s,6r)-8-methyl-3-{[(2e)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-6-yl (2e)-2-methylbut-2-enoate

C18H27NO4 (321.194)


   

9-hydroxy-n-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enimidic acid

9-hydroxy-n-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enimidic acid

C18H27NO4 (321.194)


   

(1s,3r,5r,6s)-8-methyl-3-{[(2e)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-6-yl (2e)-2-methylbut-2-enoate

(1s,3r,5r,6s)-8-methyl-3-{[(2e)-2-methylbut-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-6-yl (2e)-2-methylbut-2-enoate

C18H27NO4 (321.194)


   

2-{[(6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydroinden-4-yl)(hydroxy)methylidene]amino}-3-methylpentanoic acid

2-{[(6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydroinden-4-yl)(hydroxy)methylidene]amino}-3-methylpentanoic acid

C18H27NO4 (321.194)


   

(2r,3r)-2-({[(3as,6r,7as)-6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydroinden-4-yl](hydroxy)methylidene}amino)-3-methylpentanoic acid

(2r,3r)-2-({[(3as,6r,7as)-6-ethyl-1-oxo-2,3,3a,6,7,7a-hexahydroinden-4-yl](hydroxy)methylidene}amino)-3-methylpentanoic acid

C18H27NO4 (321.194)


   

(6e,8r)-9-hydroxy-n-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enimidic acid

(6e,8r)-9-hydroxy-n-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enimidic acid

C18H27NO4 (321.194)


   

(5r)-3-methyl-5-[(2r)-1-{4-[(2r,4r)-4-methyl-5-oxooxolan-2-yl]butyl}pyrrolidin-2-yl]-5h-furan-2-one

(5r)-3-methyl-5-[(2r)-1-{4-[(2r,4r)-4-methyl-5-oxooxolan-2-yl]butyl}pyrrolidin-2-yl]-5h-furan-2-one

C18H27NO4 (321.194)


   

(6e,8s)-9-hydroxy-n-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enimidic acid

(6e,8s)-9-hydroxy-n-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enimidic acid

C18H27NO4 (321.194)


   

3-methyl-5-{1-[4-(4-methyl-5-oxooxolan-2-yl)butyl]pyrrolidin-2-yl}-5h-furan-2-one

3-methyl-5-{1-[4-(4-methyl-5-oxooxolan-2-yl)butyl]pyrrolidin-2-yl}-5h-furan-2-one

C18H27NO4 (321.194)


   

7-{[(2-methylbutanoyl)oxy]methyl}-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 2-methylbut-2-enoate

7-{[(2-methylbutanoyl)oxy]methyl}-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 2-methylbut-2-enoate

C18H27NO4 (321.194)